Volume 82 | ESPE2014 | Next issue

ESPE 2014

Dublin, Ireland
18 Sep 2014 - 20 Sep 2014

Card image cap
Dublin, Ireland; 18-20 September 2014. Further information

Free Communications

Growth

Heterozygous IGF1R Mutations Represent a Frequent Finding in Patients with Pre- and/or Postnatal Proportional Undergrowth and Low, Normal or Supranormal IGF1
aHospital Universitario La Paz, INGEMM, IdiPAZ, UAM, Madrid, Spain; bCIBERER (U753), ISCIII, Madrid, Spain; cHospital Universitario La Paz, Pediatric Endocrinology, Madrid, Spain; dHospital Universitario Puerta de Hierro-Majadahonda, Pediatric Endocrinology, Madrid, Spain; eHospital General de Granollers, Pediatric Endocrinology, Barcelona, Spain; fHospital Vall d’Hebrón, Pediatric Endocrinology, Barcelona, Spain; gVHIR, CIBERER (U712), ISCIII, Autonomous University, Barcelona, Spain; hDepartment of Genetics, Hospital Universitari Son Espases, Palma de Mallorca, Spain; iHospital Universitari Son Espases, Pediatric Endocrinology, Palma de Mallorca, Spain; jHospital Universitario Severo Ochoa, Pediatric Endocrinology, Madrid, Spain; kHospital Universitario 12 de Octubre, Pediatric Endocrinology, Madrid, Spain
hrp0082fc4.1
The Effect of grB10-Deficiency in Zebrafish: A Translational Animal Model to Study Human Growth
aManchester Academic Health Sciences Centre, Royal Manchester Children’s Hospital, Manchester, UK; bFaculty of Life Sciences, The Michael Smith Building, University of Manchester, Manchester, UK
hrp0082fc4.2
Oscillations in Gene Expression Profiles Across Childhood Highlight the Relation of Growth and Specific Metabolic Functions in Both Sexes
aManchester Academic Health Sciences Centre, Royal Manchester Children’s Hospital, Manchester, UK; bFaculty of Life Sciences, The University of Manchester, Manchester, UK; cManchester Institute of Biotechnology, The University of Manchester, Manchester, UK
hrp0082fc4.3
Short Stature, Accelerated Bone Maturation, and Early Growth Cessation due to Heterozygous Aggrecan Mutations
aProgram in Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA; bPediatric Endocrinology Unit, Department of Women’s and Children’s Health, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden; cDivision of Endocrinology, Boston Children’s Hospital, Boston, Massachusetts, USA; dConnecticut Children’s Medical Center, Hartford, Connecticut, USA; eChildren’s Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA; fDepartment of Genetics, Harvard Medical School, Boston, Massachusetts, USA; gProgram in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, USA
hrp0082fc4.4
Fetal and Postnatal Growth in Turner Syndrome and their Associations with the Dosage Effects of the X-Linked Gene: a Cross-Sectional Data Base Analysis of the French National Rare Disease Network
aPaediatric Endocrinology Diabetology, Robert Debre Hospital, Assistance Publique Hopitaux de Paris, Université Paris Diderot, Paris, France; bReference Center for Rare Endocrine Growth Diseases, Paris, France; cClinical Epidemiology Department, Robert Debre Hospital, Assistance Publique Hopitaux de Paris, Université Paris Diderot, Paris, France; dFrench Endocrine Rare Diseases for Growth Network, Cemara, France
hrp0082fc4.5